C. Riché

1.6k total citations
51 papers, 1.3k citations indexed

About

C. Riché is a scholar working on Oncology, Pharmacology and Pharmacology. According to data from OpenAlex, C. Riché has authored 51 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 19 papers in Pharmacology and 10 papers in Pharmacology. Recurrent topics in C. Riché's work include Pharmacogenetics and Drug Metabolism (19 papers), Cancer Treatment and Pharmacology (13 papers) and Drug Transport and Resistance Mechanisms (9 papers). C. Riché is often cited by papers focused on Pharmacogenetics and Drug Metabolism (19 papers), Cancer Treatment and Pharmacology (13 papers) and Drug Transport and Resistance Mechanisms (9 papers). C. Riché collaborates with scholars based in France, Switzerland and Belgium. C. Riché's co-authors include F. Berthou, Philippe Beaune, Damrong Ratanasavanh, Yvonne Dréano, Jacques Robert, Marie‐Christine Haaz, Laurent P. Rivory, A. Guillouzo, D. Picart and Laurent Vernillet and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Biochemical Pharmacology.

In The Last Decade

C. Riché

49 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Riché France	18	585	454	386	239	121	51	1.3k
Hyung‐Keun Roh South Korea	17	807 1.4×	352 0.8×	294 0.8×	217 0.9×	138 1.1×	29	1.4k
Michel Eichelbaum Germany	10	790 1.4×	395 0.9×	286 0.7×	136 0.6×	232 1.9×	12	1.3k
L. Vereczkey Hungary	21	547 0.9×	358 0.8×	341 0.9×	182 0.8×	173 1.4×	89	1.4k
Joanna M. Little United States	21	661 1.1×	415 0.9×	658 1.7×	119 0.5×	195 1.6×	36	1.5k
Nadia Soukhova United States	14	720 1.2×	380 0.8×	302 0.8×	214 0.9×	137 1.1×	18	1.4k
R. Böcker Germany	19	509 0.9×	284 0.6×	275 0.7×	153 0.6×	90 0.7×	51	1.1k
JoAnn Scatina United States	22	681 1.2×	318 0.7×	483 1.3×	251 1.1×	139 1.1×	56	1.6k
B. K. Park United Kingdom	21	646 1.1×	275 0.6×	259 0.7×	340 1.4×	220 1.8×	39	1.6k
Roman A. McLellan Sweden	11	889 1.5×	396 0.9×	489 1.3×	157 0.7×	161 1.3×	13	1.3k
Sonia M. F. de Morais United States	11	1.0k 1.7×	506 1.1×	342 0.9×	207 0.9×	251 2.1×	11	1.5k

Countries citing papers authored by C. Riché

Since Specialization

Citations

This map shows the geographic impact of C. Riché's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Riché with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Riché more than expected).

Fields of papers citing papers by C. Riché

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Riché. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Riché. The network helps show where C. Riché may publish in the future.

Co-authorship network of co-authors of C. Riché

This figure shows the co-authorship network connecting the top 25 collaborators of C. Riché. A scholar is included among the top collaborators of C. Riché based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Riché. C. Riché is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Robert, Jacques, et al.. (2002). Effects of paclitaxel, cyclophosphamide, ifosfamide, tamoxifen and cyclosporine on the metabolism of methoxymorpholinodoxorubicin in human liver microsomes. Cancer Chemotherapy and Pharmacology. 49(4). 274–280. 10 indexed citations

Becquemont, Laurent, et al.. (1997). Influence of the CYP1A2 inhibitor fluvoxamine on tacrine pharmacokinetics in humans*. Clinical Pharmacology & Therapeutics. 61(6). 619–627. 42 indexed citations

Haaz, Marie‐Christine, Laurent P. Rivory, C. Riché, & Jacques Robert. (1997). The transformation of irinotecan (CPT-11) to its active metabolite SN-38 by human liver microsomes Differential hydrolysis for the lactone and carboxylate forms. Naunyn-Schmiedeberg s Archives of Pharmacology. 356(2). 257–262. 54 indexed citations

Berson, Alain, Sylvaine Renault, P Lettéron, et al.. (1996). Uncoupling of rat and human mitochondria: A possible explanation for tacrine-induced liver dysfunction. Gastroenterology. 110(6). 1878–1890. 60 indexed citations

Riché, C., et al.. (1996). A cellular model for drug interactions on hematopoiesis: The use of human umbilical cord blood progenitors as a model for the study of drug-related myelosuppression of normal hematopoiesis. Cell Biology and Toxicology. 12(1). 39–53. 16 indexed citations

Ratanasavanh, Damrong, et al.. (1996). Metabolism and toxicity of coumarin on cultured human, rat, mouse and rabbit hepatocytes. Fundamental and Clinical Pharmacology. 10(6). 504–510. 31 indexed citations

Becquemont, Laurent, et al.. (1996). Influence of fluvoxamine on tacrine metabolism in vitro: potential implication for the hepatotoxicity in vivo*. Fundamental and Clinical Pharmacology. 10(2). 156–157. 10 indexed citations

Robert, Jacques, et al.. (1994). Modulation of anthracycline accumulation and metabolism in rat hepatocytes in culture by three revertants of multidrug resistance. Cancer Chemotherapy and Pharmacology. 35(1). 53–58. 4 indexed citations

Riché, C., et al.. (1994). P-glycoprotein expression and function in rat hepatocytes in culture. Biochemical Pharmacology. 47(12). 2302–2306. 5 indexed citations

10.

Berthou, F., B. Guillois, C. Riché, et al.. (1992). Interspecies variations in caffeine metabolism related to cytochrome P4501A enzymes. Xenobiotica. 22(6). 671–680. 101 indexed citations

11.

Dréano, Yvonne, et al.. (1991). Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes. Biochemical Pharmacology. 41(12). 1911–1919. 162 indexed citations

12.

Berthou, F., et al.. (1991). Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes.. Drug Metabolism and Disposition. 19(3). 561–567. 111 indexed citations

13.

Ratanasavanh, Damrong, et al.. (1990). Methylcholanthrene but not phenobarbital enhances caffeine and theophylline metabolism in cultured adult human hepatocytes. Biochemical Pharmacology. 39(1). 85–94. 19 indexed citations

14.

Berthou, F., et al.. (1989). Comparison of Caffeine Metabolism by Slices, Microsomes and Hepatocyte Cultures from Adult Human Liver. Xenobiotica. 19(4). 401–417. 85 indexed citations

15.

Riché, C., et al.. (1989). Solid phase extraction and HPLC determination of spiramycin in plasma and vitreous concentrations. Biomedical Chromatography. 3(1). 1–4. 8 indexed citations

16.

Lachâtre, Gérard, et al.. (1989). SINGLE‐DOSE PHARMACOKINETICS OF AMINEPTINE AND OF ITS MAIN METABOLITE IN HEALTHY YOUNG ADULTS. Fundamental and Clinical Pharmacology. 3(1). 19–26. 7 indexed citations

17.

Berthou, F., et al.. (1988). Caffeine and theophylline metabolism in newborn and adult human hepatocytes; comparison with adult rat hepatocytes. Biochemical Pharmacology. 37(19). 3691–3700. 51 indexed citations

18.

Robert, Jacques, et al.. (1988). Different cytotoxicity and metabolism of doxorubicin, daunorubicin, epirubicin, esorubicin and idarubicin in cultured human and rat hepatocytes. Biochemical Pharmacology. 37(20). 3877–3887. 61 indexed citations

19.

Riché, C., et al.. (1987). Study of doxorubicin photodegradation in plasma, urine and cell culture medium by HPLC. Biomedical Chromatography. 2(6). 242–244. 13 indexed citations

20.

Berthou, F., et al.. (1982). [Specificity of methods for theophylline in biological samples: therapeutic consequences (author's transl)].. PubMed. 37(1). 53–64. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact